Fisher Completes Acquisition of Dharmacon | GenomeWeb

NEW YORK, April 2 (GenomeWeb News) - Fisher Scientific International has completed its acquisition of RNAi company Dharmacon, Fisher said yesterday.

 

Fisher bought Dharmacon, which is based in Lafayette, Colo., for $80 million in cash. The deal was first announced in February.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.